On this week’s episode, we discussed xenotransplantation, which could change how organ transplants are performed, withDr. Joseph Tector, a transplant surgeon at the Miami Transplant Institute and the founder of Makana Therapeutics.
We also examined a new research trial of a brain hemorrhage treatment called recombinant activated clotting factor VII (rFVIIa). The FASTEST trial could revolutionize the way doctors approach brain bleeding, says Dr. Lauren Ng, the principal investigator for the trial and a critical care physician at Mayo Clinic Jacksonville.
